About Serenus

Serenus Biotherapeutics is a privately held specialty biopharmaceutical company that specializes in in-licensing, registering, and commercializing U.S. Food and Drug Administration, European Medicines Association and Japan’s Pharmaceutical and Medical Devices Agency approved therapeutics to address unmet medical needs with high regional prevalence in the Sub Saharan African market.

With an executive management team that has more than three decades of biopharmaceutical industry experience in the United States, Europe, the Middle East, and Africa, Serenus is an ideal partner of choice for in-licensing opportunities for biopharmaceutical companies interested in expanding access to their novel therapies in the Sub-Saharan Africa healthcare system.

We are experts in managing product approvals, pricing, reimbursement, distribution, compliancy, and ethical marketing practices on the Sub-Saharan regional and national level.